By identifying cell lines and breast cancers, tissue cell clusters that classify as HER2 + through consistent and significant gene expression in their population (pct > 0.5 with expression > 0.5), assisted gene sets are developed for this relevant disease subtype model system. This evidence concerns the gene ERBB2 and breast carcinoma.